Track record · closed signal

Encompass Health Corp (EHC) — closed signal from April 6, 2026

Partial Published before the outcome was known, scored automatically when the window closed on July 5, 2026 — +4.3% at the close.

Predicted vs. what happened

EHC price · publication thesis → realized outcomesplit-adjusted

$99.00 – $103.00Entry zone — fair-value band

$102.09Published — price the day we called it

$114.34Target — the price the thesis aimed for

$109.89Peak — highest point inside the window, not a realized return

$106.46Window close — end-of-window price, context only

What happened

Partial

Reached 63% of the predicted growth at its peak, without hitting the target.

At window close

+4.3%

realized, from the publication price to the last close inside the window

Peak gain

+7.6%

peak, from the publication price — not a realized return

S&P 500, same window

+13.3%

SPY over the identical days, dividend-adjusted

Window close

$106.46

last close inside the window, ended July 5, 2026

Peak price

$109.89

peak on May 13, 2026 — not a realized return

Days to target

—

The thesis — published April 6, 2026

Predicted growth

+12%

over the measurement window

Target price

$114.34

the price the thesis aimed for

Entry zone

$99.00 – $103.00

the fair-value band we waited for

Price at publication

$102.09

published April 6, 2026

Confidence

75%

how strongly the data lined up

Timeframe

Short-term (0–3 months)

Encompass Health runs rehab hospitals, which tend to do okay when the market is unstable. Earnings have been consistent, and a new Delaware hospital gives a clear growth event. Shares are staying near a support level instead of falling apart, but the company carries debt and trading interest is modest, so the setup is better viewed as a careful watch than a top growth pick.

Primary drivers

Steady demand for rehab care keeps revenue more predictable
Reliable earnings make future results easier to see
A new Delaware hospital is a clear, company-level growth event
Stock holding support despite low trading shows relative resilience

How it played out

EHC: rose 7.6%, but the target was not reached

Lyra expected EHC to rise 12% from its publication price of $102.09. The thesis pointed to steady demand for rehabilitation care, reliable earnings, a planned Delaware hospital, and shares holding support despite modest trading interest. Debt remained a stated risk.

EHC peaked at $109.89 on May 13, a gain of 7.6%. It stayed below the $114.34 target and ended the window at $106.46 on July 5. The thesis partially played out because the stock rose, but the expected gain was not reached.

What happened during the window

On April 30, Encompass Health reported first-quarter revenue of $1,586.6 million, up 9.0%, and increased its full-year guidance. On May 5, it opened a 50-bed rehabilitation hospital in Pennsylvania.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All EHC signals